Company profile: Clinilabs
1.1 - Company Overview
Company description
- Provider of clinical drug development services specializing in CNS medications, from first-in-human to Phase 3 trials. Offers global site selection via a network in 42 countries, decentralized trials using telemedicine, electronic tools, remote assessment and wearables, corelab data services to centralize and improve data accuracy, and centralized PSG and EEG capture and analysis for clinical trials.
Products and services
- CNS Drug Development: Clinilabs delivers CNS-specialized clinical development services to businesses, running first-in-human through Phase 3 trials for CNS medications
- Decentralized Trials: Clinilabs orchestrates remote-enabled trials that minimize in-clinic visits using telemedicine, electronic tools, remote assessment, and wearable devices
- Site Selection: Clinilabs leverages global-scale CNS clinical trial site networks across 42 countries, ensuring access to patients and high-quality data
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Clinilabs
Evotec
HQ: Germany
Website
- Description: Provider of drug discovery and gene therapy solutions, delivering CRO/CDMO services from initial research to clinical trials; AI-powered PanOmics and iPSC technologies for disease understanding in small molecules and biotherapeutics; hit identification; J.POD continuous biomanufacturing for biologics; and a proprietary ion channel assay.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evotec company profile →
J+D Forecasting
HQ: United Kingdom
Website
- Description: Provider of pharmaceutical forecasting software, pharma training, and consultancy services as a business consulting firm.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full J+D Forecasting company profile →
Aptus Clinical
HQ: United Kingdom
Website
- Description: Provider of specialist clinical contract research services, offering Catalyst Oncology, a clinical research organization focusing on oncology supporting biotech companies in developing cancer therapies, and Catalyst Flex, multi-therapeutic functional service provider solutions including clinical operations, data management, biostatistics, programming, safety, and medical writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aptus Clinical company profile →
Syra Health
HQ: United States
Website
- Description: Provider of healthcare and managed-care solutions grounded in real-world evidence and insights, including a mental and behavioral health platform for assessments, education, symptom monitoring, and interventions; an EMR to streamline clinical workflows and manage patient health information; a real-time patient engagement bot; workforce staffing and MSPs; a population health insights hub; and education and training.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syra Health company profile →
Adare Pharma Solutions
HQ: United States
Website
- Description: Provider of global technology-driven CDMO services spanning research, business and product development, formulation development (taste masking, customized release, patient-centered dosage forms), analytical services, clinical trial materials manufacturing and packaging (GMP and Non-GMP), commercial manufacturing, packaging, and logistical support, with delivery technologies including Diffucaps®, Microcaps®, and Optimμm®.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adare Pharma Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Clinilabs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Clinilabs
2.2 - Growth funds investing in similar companies to Clinilabs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Clinilabs
4.2 - Public trading comparable groups for Clinilabs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →